INTCO Medical Wins Two Accolades at “Times Finance Kumquat Award”

The Influence·Times Sustainable Development & Innovation Annual Conference—organized by the esteemed Time Media Group—recently concluded in Chengdu, Sichuan. Centered on sustainable development and innovation, the event brought together industry experts, academic leaders, and distinguished corporate representatives to discuss forward-looking trends shaping high-quality growth.

At the conference, the 10th Golden Tangerine Ceremony of Time Finance was successfully held. INTCO Medical Technology Co., Ltd. (Stock Code: 300677) stood out for its strong operational resilience and solid market performance, earning the prestigious title of “High-Quality Development Listed Company.” Additionally, Ms. Feng Jie, Board Secretary of INTCO Medical, was honored as the “Annual Outstanding Innovative Board Secretary.”

These recognitions underscore the high standards of the Times Finance Kumquat Award, which is widely respected in the financial community for its rigorous, professional, and impartial evaluation system. INTCO Medical’s award reflects clear acknowledgment—from both the judging committee and the broader market—of the company’s accomplishments in economic value creation, innovation capability, governance practices, and social contribution.

Over the past year, despite a continuously evolving external environment, INTCO Medical has remained firmly committed to its long-term strategy of high-quality development. The company has strengthened its foundational business segments, reinforced its global leadership in the disposable gloves industry, and made substantial progress in technological innovation, intelligent manufacturing, and internationalization. By optimizing its product mix, improving operational efficiency, and implementing ESG practices, INTCO Medical has achieved parallel growth in both financial performance and social impact, further establishing itself as an industry benchmark.

Meanwhile, the honor awarded to Ms. Feng Jie highlights the capital market’s recognition of her contributions in corporate governance, investor communication, and capital market innovation. As a key link between the company and investors, Ms. Feng—together with the Capital Securities team—has upheld a high standard of transparent, accurate, and timely information disclosure. INTCO Medical’s “Class A (Excellent)” result in the 2024 annual information disclosure assessment stands as strong proof of the trust regulators and the public place in the company’s standardized operations and disclosure quality.

Together, these two accolades hold significant meaning for INTCO Medical. They serve not only as affirmation of its progress to date but also as encouragement to continue advancing with determination and innovation.

Looking ahead, INTCO Medical will continue to pursue high-quality growth driven by technological innovation and guided by sustainable development principles. Building on this new recognition, the company will deepen its global strategy, accelerate industrial upgrades, and deliver greater value to investors, customers, and society. INTCO Medical will remain committed to steady, long-term development as it progresses toward new milestones.